Atara Biotherapeutics, Inc.

ATRA
$8.23 (- $0.16 - 1.91%)
Last updated: 2026-07-20 15:38 UTC
ATRA Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS0465131078
CUSIP046513107
Market Price8.23
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio6.12
EPS2.86
Market Cap$126.2M
Book Value-5.08
Price to Book-3.444
Beta0.67
52w High18.95
52w Low5.0
Next Earnings DateN/A

Atara Biotherapeutics, Inc. trades under ticker ATRA on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US0465131078, CUSIP 046513107. Also searched as Atara Biotherapeutics.

Related researchATRA stock priceATRA share price046513107Atara Biotherapeutics stockAtara Biotherapeutics share price
About the Company
Atara Biotherapeutics Inc. is a biopharmaceutical company focused on developing innovative cell therapies and immunotherapies for patients with serious diseases. The company specializes in creating therapeutic solutions that address critical unmet medical needs across oncology and other disease areas. Atara Biotherapeutics leverages advanced cellular and molecular approaches to design treatments that can potentially offer significant clinical benefits. The company operates in the competitive biopharmaceutical sector, where it collaborates with research institutions, clinical partners, and investors to advance its pipeline of therapeutic candidates through development and regulatory pathways. Founded and headquartered in the United States, Atara Biotherapeutics represents the biotechnology industry's commitment to translating scientific innovation into transformative medical treatments for patients worldwide.
Price History